Johnson & Johnson Biom X Inc. Transaction History
Johnson & Johnson
- $314 Million
- Q3 2024
A detailed history of Johnson & Johnson transactions in Biom X Inc. stock. As of the latest transaction made, Johnson & Johnson holds 192,321 shares of PHGE stock, worth $107,699. This represents 0.06% of its overall portfolio holdings.
Number of Shares
192,321
Previous 1,923,201
90.0%
Holding current value
$107,699
Previous $653,000
69.98%
% of portfolio
0.06%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding PHGE
# of Institutions
2Shares Held
301KCall Options Held
0Put Options Held
0About BiomX Inc.
- Ticker PHGE
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,982,300
- Market Cap $16.8M
- Description
- BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...